G1 Therapeutics Inc (GTHX)
4.355
-0.12
(-2.57%)
USD |
NASDAQ |
Mar 28, 14:26
G1 Therapeutics Price: 4.355 for March 28, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Mar 27, 2024 | 4.29 | 4.765 | 4.28 | 4.47 | 1.559M |
Mar 26, 2024 | 4.17 | 4.39 | 4.120 | 4.29 | 832044.0 |
Mar 25, 2024 | 3.96 | 4.35 | 3.92 | 4.14 | 1.252M |
Mar 22, 2024 | 3.72 | 4.09 | 3.69 | 4.00 | 1.145M |
Mar 21, 2024 | 3.45 | 3.74 | 3.45 | 3.70 | 990191.0 |
Mar 20, 2024 | 3.22 | 3.48 | 3.20 | 3.45 | 889881.0 |
Mar 19, 2024 | 3.20 | 3.420 | 3.135 | 3.28 | 672572.0 |
Mar 18, 2024 | 3.18 | 3.40 | 2.933 | 3.21 | 815320.0 |
Mar 15, 2024 | 3.11 | 3.24 | 3.06 | 3.11 | 440514.0 |
Mar 14, 2024 | 3.43 | 3.44 | 3.10 | 3.12 | 548294.0 |
Mar 13, 2024 | 3.31 | 3.50 | 3.31 | 3.46 | 492873.0 |
Mar 12, 2024 | 3.51 | 3.554 | 3.16 | 3.32 | 822182.0 |
Mar 11, 2024 | 3.66 | 3.78 | 3.48 | 3.48 | 390645.0 |
Mar 08, 2024 | 3.58 | 3.755 | 3.545 | 3.64 | 448672.0 |
Mar 07, 2024 | 3.59 | 3.64 | 3.44 | 3.58 | 737310.0 |
Mar 06, 2024 | 3.55 | 3.64 | 3.45 | 3.53 | 609122.0 |
Mar 05, 2024 | 3.63 | 3.74 | 3.50 | 3.54 | 730663.0 |
Mar 04, 2024 | 3.85 | 3.87 | 3.45 | 3.66 | 1.157M |
Mar 01, 2024 | 3.27 | 3.84 | 3.27 | 3.73 | 1.915M |
Feb 29, 2024 | 3.20 | 3.56 | 3.20 | 3.32 | 1.716M |
Feb 28, 2024 | 2.55 | 3.385 | 2.50 | 3.33 | 5.030M |
Feb 27, 2024 | 2.36 | 2.49 | 2.27 | 2.40 | 1.349M |
Feb 26, 2024 | 2.22 | 2.35 | 2.20 | 2.30 | 657294.0 |
Feb 23, 2024 | 2.19 | 2.31 | 2.12 | 2.22 | 1.178M |
Feb 22, 2024 | 2.16 | 2.225 | 2.05 | 2.15 | 2.379M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.12
Minimum
Oct 09 2023
40.58
Maximum
Sep 11 2019
13.39
Average
12.92
Median
Price Benchmarks
Amicus Therapeutics Inc | 11.65 |
Geron Corp | 3.315 |
Palatin Technologies Inc | 1.815 |
Oragenics Inc | 1.42 |
TG Therapeutics Inc | 15.33 |
Price Related Metrics
PS Ratio | 2.854 |
Price to Book Value | 6.424 |
Earnings Yield | -21.81% |
Market Cap | 227.33M |